57
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Adherence to statin treatment following a myocardial infarction: an Italian population-based survey

, , , , , , , , , , & show all
Pages 273-280 | Published online: 01 Jun 2015

References

  • [No authors listed]Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)Lancet1994344138313897968073
  • LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-upLancet20023591379138711978335
  • Heart Protection Study Collaborative GroupMRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals; a randomised placebo-controlled trialLancet200236072212114036
  • LaRosaJCGrundySMWatersDDIntensive lipid lowering with atorvastatin in patients with stable coronary diseaseN Engl J Med20053521425143515755765
  • SchwartzGGOlssonAGEzekowitzMDEffects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trialJAMA20012851711171811277825
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA20012852486249711368702
  • De BackerGAmbrosioniEBorch-JohnsenKEuropean guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical PracticeEur Heart J2003241601161012964575
  • SmithSCAllenJBlairSAHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood InstituteCirculation20061132363237216702489
  • National Committee for Quality AssuranceThe State of Managed Care QualityWashingtonNCQA1999
  • HoPMMagidDJShetterlySMMedication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery diseaseAm Heart J2008155722729
  • ShahNDDunlaySMTingHHLong-term medication adherence after myocardial infarction: experience of a communityAm J Med2009122e7e1319560749
  • EagleKAMontoyeCKRibaALGuideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction: the American College of Cardiology’s Guidelines Applied in Practice (GAP) Projects in MichiganJ Am Coll Cardiol2005461242124816198838
  • MuhlesteinJBHorneBDBairTLUsefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortalityAm J Cardiol20018725726111165956
  • Di BariMBalziDRobertsATPrognostic stratification of folder persons based on simple administrative data: development and validation of the “Silver Code,” to be used in emergency department triageJ Gerontol A Biol Sci Med Sci20106515916419349591
  • Ministero del Lavoro, della Salute e delle Politiche SocialiRapporto annuale sulle attivita’ di ricovero ospedaliero2005 Available from: http://www.salute.gov.it/Accessed April 24, 2009
  • WHO Collaborating Centre for Drug Statistics Methodology [website on the Internet] Available from: http://www.whocc.noAccessed October 14, 2014
  • CatalanVSLeLorierJPredictors of long-term persistence on statins in a subsidized clinical populationValue Health2000341742616464201
  • WeiLWangJThompsonPWongSStruthersADMacDonaldTMAdherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up studyHeart20028822923312181210
  • CaliffRMDeLongEOstbyteTUnderuse of aspirin in a referral population with documented coronary artery diseaseAm J Cardiol20028965366111897205
  • NewbyLKLaPointeNMChenAYLong-term adherence to evidence-based secondary prevention therapies in coronary artery diseaseCirculation200611320321216401776
  • MehtaRHMontoyeCKGalloglyMImproving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) InitiativeJAMA20022871269127611886318
  • LaBreshKAEllrodtAGGliklichRLiljestrandJPetoRGet with the guidelines for cardiovascular secondary prevention: pilot resultsArch Intern Med200416420320914744845
  • BrophyJMCostaVStatin wars following coronary revascularization – evidence-based clinical practice?Can J Cardiol200622545816450018
  • FonarowGCGawlinskiAMoughrabiSTillischJHImproved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)Am J Cardiol20018781982211274933
  • SimpsonEBeckCRichardHEisenbergMJPiloteLDrug prescriptions after acute myocardial infarction: dosage, compliance, and persistenceAm Heart J200314543844412660666
  • SpencerFAFonarowGCFrederickPDEarly withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: National Registry of Myocardial InfarctionArch Intern Med20041642162216815505131
  • JackeviciusCAMamdaniMTuJVAdherence with statin therapy in elderly patients with and without acute coronary syndromesJAMA200228846246712132976
  • JickSSKayeJAVasilakis-ScaramozzaCValidity of the general practice research databasePharmacotherapy20032368668912741446
  • Cholesterol Treatment Trialists (CTT) CollaborationBaigentCBlackwellLEfficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trialsLancet20103761670168121067804
  • DaskalopoulouSSDelaneyJAFilionKBBrophyJMMayoNESuissaSDiscontinuation of statin therapy following an acute myocardial infarction: a population-based studyEur Heart J2008292083209118664465